Start Date
October 31, 2023
Primary Completion Date
May 31, 2024
Study Completion Date
May 31, 2024
Association of lurbinectedin and durvalumab
"A treatment cycles consists of 3 weeks (i.e. 21 days). Lurbinectedin will be administered by intravenous infusion on Day 1 every 3 weeks.~Durvalumab will be administered by intravenous infusion on Day 1 every 3 weeks."
Association of carboplatin and etoposide
"Treatment will be administered on a 21-days cycle basis up to a maximum of 6 cycles.~Carboplatin will be administered by intravenous infusion on Day 1 every 3 weeks.~Etoposide will be administered by intravenous infusion on Day 1-3 every 3 weeks"
Institut Bergonié, Bordeaux
Lead Sponsor
Collaborators (2)
AstraZeneca
INDUSTRY
PharmaMar
INDUSTRY
Institut Bergonié
OTHER